ANDAORALTABLET
Approved
Jul 2011
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
20
Mechanism of Action
alpha Glucosidase Inhibitors
Pharmacologic Class:
alpha-Glucosidase Inhibitor
Indications (1)
Clinical Trials (5)
A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D)
Started Dec 2020
2,000 enrolled
Type 2 Diabetes Mellitus
Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose
Started Mar 2020
85 enrolled
Diabetes Mellitus, Type 2
Bioequivalence Study for Acarbose/Metformin FDC
Started Oct 2019
24 enrolled
Diabetes Mellitus, Type 2
Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive
Started Jun 2019
1,293 enrolled
Type 2 Diabetes Mellitus
A Study for Sufficient Acarbose Decreased Glucose Excursion in Type 2 Diabetic Patients
Started Jan 2019
900 enrolled
Type 2 Diabetes MellitusPoor Glycemic Control